<html xmlns:v="urn:schemas-microsoft-com:vml" xmlns:o="urn:schemas-microsoft-com:office:office" xmlns:w="urn:schemas-microsoft-com:office:word" xmlns:m="http://schemas.microsoft.com/office/2004/12/omml" xmlns="http://www.w3.org/TR/REC-html40"><head><meta http-equiv=Content-Type content="text/html; charset=us-ascii"><meta name=Generator content="Microsoft Word 14 (filtered medium)"><style><!--
/* Font Definitions */
@font-face
{font-family:Calibri;
panose-1:2 15 5 2 2 2 4 3 2 4;}
@font-face
{font-family:Tahoma;
panose-1:2 11 6 4 3 5 4 4 2 4;}
@font-face
{font-family:Georgia;
panose-1:2 4 5 2 5 4 5 2 3 3;}
@font-face
{font-family:"Lucida Sans Unicode";
panose-1:2 11 6 2 3 5 4 2 2 4;}
/* Style Definitions */
p.MsoNormal, li.MsoNormal, div.MsoNormal
{margin:0in;
margin-bottom:.0001pt;
font-size:11.0pt;
font-family:"Calibri","sans-serif";}
a:link, span.MsoHyperlink
{mso-style-priority:99;
color:blue;
text-decoration:underline;}
a:visited, span.MsoHyperlinkFollowed
{mso-style-priority:99;
color:purple;
text-decoration:underline;}
p.MsoPlainText, li.MsoPlainText, div.MsoPlainText
{mso-style-priority:99;
mso-style-link:"Plain Text Char";
margin:0in;
margin-bottom:.0001pt;
font-size:11.0pt;
font-family:"Arial","sans-serif";}
p.MsoAcetate, li.MsoAcetate, div.MsoAcetate
{mso-style-priority:99;
mso-style-link:"Balloon Text Char";
margin:0in;
margin-bottom:.0001pt;
font-size:8.0pt;
font-family:"Tahoma","sans-serif";}
span.PlainTextChar
{mso-style-name:"Plain Text Char";
mso-style-priority:99;
mso-style-link:"Plain Text";
font-family:"Arial","sans-serif";}
span.BalloonTextChar
{mso-style-name:"Balloon Text Char";
mso-style-priority:99;
mso-style-link:"Balloon Text";
font-family:"Tahoma","sans-serif";}
.MsoChpDefault
{mso-style-type:export-only;
font-family:"Calibri","sans-serif";}
@page WordSection1
{size:8.5in 11.0in;
margin:1.0in 1.0in 1.0in 1.0in;}
div.WordSection1
{page:WordSection1;}
--></style><!--[if gte mso 9]><xml>
<o:shapedefaults v:ext="edit" spidmax="1026" />
</xml><![endif]--><!--[if gte mso 9]><xml>
<o:shapelayout v:ext="edit">
<o:idmap v:ext="edit" data="1" />
</o:shapelayout></xml><![endif]--></head><body lang=EN-US link=blue vlink=purple><div class=WordSection1><p class=MsoPlainText><span style='font-size:12.0pt;font-family:"Calibri","sans-serif";color:#1F497D'>Tom asked, “Does anybody know if court-ordered castration curtail the possibility of a pedophile re-offending (especially in the case of a serial pedphile)?”<o:p></o:p></span></p><p class=MsoPlainText><span style='font-size:12.0pt;font-family:"Calibri","sans-serif";color:#1F497D'><o:p> </o:p></span></p><p class=MsoPlainText><span style='font-size:12.0pt;font-family:"Calibri","sans-serif";color:#1F497D'>The best answer I know is . . . it depends. For those interested in reading more, check out this 2007 article from the Mayo Clinic Proceedings:<o:p></o:p></span></p><p class=MsoPlainText><o:p> </o:p></p><p class=MsoPlainText><a href="http://www.mayoclinicproceedings.com/content/82/4/457.full">http://www.mayoclinicproceedings.com/content/82/4/457.full</a><o:p></o:p></p><p class=MsoPlainText><b><span lang=EN style='font-size:12.0pt;font-family:"Georgia","serif";color:#403838'>A Profile of Pedophilia: Definition, Characteristics of Offenders, Recidivism, Treatment Outcomes, and Forensic Issues</span></b><span style='font-size:12.0pt'><o:p></o:p></span></p><p class=MsoPlainText><o:p> </o:p></p><p class=MsoPlainText><span style='font-size:12.0pt;font-family:"Calibri","sans-serif";color:#1F497D'>Here's an excerpt from the “Treatment” section:<o:p></o:p></span></p><p class=MsoPlainText><o:p> </o:p></p><p class=MsoNormal style='mso-margin-top-alt:11.25pt;margin-right:0in;margin-bottom:11.25pt;margin-left:1.0in;text-align:justify'><span lang=EN style='font-size:9.5pt;font-family:"Lucida Sans Unicode","sans-serif";color:#403838'>Individuals can offend again while in active psychotherapy, while receiving pharmacologic treatment, and even after castration.</span><sup><span lang=EN style='font-size:8.0pt;font-family:"Lucida Sans Unicode","sans-serif";color:#403838'><a href="http://www.mayoclinicproceedings.com/content/82/4/457.full#ref-17" id=xref-ref-17-5>17</a></span></sup><span lang=EN style='font-size:9.5pt;font-family:"Lucida Sans Unicode","sans-serif";color:#403838'> Currently, much of the focus of pedophilic treatment is on stopping further offenses against children rather than altering the pedophile's sexual orientation toward children. Schober et al</span><sup><span lang=EN style='font-size:8.0pt;font-family:"Lucida Sans Unicode","sans-serif";color:#403838'><a href="http://www.mayoclinicproceedings.com/content/82/4/457.full#ref-34" id=xref-ref-34-5>34</a></span></sup><span lang=EN style='font-size:9.5pt;font-family:"Lucida Sans Unicode","sans-serif";color:#403838'> found that individuals still showed sexual interest in children, as measured by the AASI, even after a year of combined psychotherapy and pharmacotherapy, whereas the pedophiles' self-reported frequency of urges and masturbation had decreased. These findings indicate that the urges can be managed, but the core attraction does not change.</span><sup><span lang=EN style='font-size:8.0pt;font-family:"Lucida Sans Unicode","sans-serif";color:#403838'><a href="http://www.mayoclinicproceedings.com/content/82/4/457.full#ref-34" id=xref-ref-34-6>34</a>,<a href="http://www.mayoclinicproceedings.com/content/82/4/457.full#ref-64" id=xref-ref-64-2>64</a></span></sup><span lang=EN style='font-size:9.5pt;font-family:"Lucida Sans Unicode","sans-serif";color:#403838'> Other interventions designed to manage these pedophilic urges include careful forensic and therapeutic monitoring and reporting, use of testosterone-lowering medications, use of SSRIs, and surgical castration.</span><sup><span lang=EN style='font-size:8.0pt;font-family:"Lucida Sans Unicode","sans-serif";color:#403838'><a href="http://www.mayoclinicproceedings.com/content/82/4/457.full#ref-34" id=xref-ref-34-7>34</a>,<a href="http://www.mayoclinicproceedings.com/content/82/4/457.full#ref-64" id=xref-ref-64-3>64</a></span></sup><span lang=EN style='font-size:9.5pt;font-family:"Lucida Sans Unicode","sans-serif";color:#403838'><o:p></o:p></span></p><p class=MsoNormal style='mso-margin-top-alt:11.25pt;margin-right:0in;margin-bottom:11.25pt;margin-left:1.0in;text-align:justify'><span lang=EN style='font-size:9.5pt;font-family:"Lucida Sans Unicode","sans-serif";color:#403838'>A popular treatment option is testosterone suppression by pharmacologic means (eg, antiandrogenic therapy or chemical castration). We are aware of only one state (Texas) that will pay for physical castration of sexual offenders but not for long-term chemical castration.</span><sup><span lang=EN style='font-size:8.0pt;font-family:"Lucida Sans Unicode","sans-serif";color:#403838'><a href="http://www.mayoclinicproceedings.com/content/82/4/457.full#ref-85" id=xref-ref-85-1>85</a></span></sup><span lang=EN style='font-size:9.5pt;font-family:"Lucida Sans Unicode","sans-serif";color:#403838'> Although physical castration seems definitive in preventing repeated sexual offenses, some physically castrated pedophiles have restored their potency by taking exogenous testosterone and then abused again.</span><sup><span lang=EN style='font-size:8.0pt;font-family:"Lucida Sans Unicode","sans-serif";color:#403838'><a href="http://www.mayoclinicproceedings.com/content/82/4/457.full#ref-17" id=xref-ref-17-6>17</a></span></sup><span lang=EN style='font-size:9.5pt;font-family:"Lucida Sans Unicode","sans-serif";color:#403838'> Chemical castration has many advantages over physical castration. It requires follow-up visits, continuous monitoring, and psychiatric reevaluation to continue the medication and is reversible for health reasons.</span><sup><span lang=EN style='font-size:8.0pt;font-family:"Lucida Sans Unicode","sans-serif";color:#403838'><a href="http://www.mayoclinicproceedings.com/content/82/4/457.full#ref-64" id=xref-ref-64-5>64</a></span></sup><span lang=EN style='font-size:9.5pt;font-family:"Lucida Sans Unicode","sans-serif";color:#403838'> Agents such as medroxyprogesterone acetate, leuprolide acetate, cyproterone acetate, luteinizing hormone-releasing hormone, and gonadotropin-releasing hormone agonists have all been studied as forms of treatment and all work by suppressing testosterone levels</span><sup><span lang=EN style='font-size:8.0pt;font-family:"Lucida Sans Unicode","sans-serif";color:#403838'><a href="http://www.mayoclinicproceedings.com/content/82/4/457.full#ref-5" id=xref-ref-5-19>5</a>,<a href="http://www.mayoclinicproceedings.com/content/82/4/457.full#ref-14" id=xref-ref-14-5>14</a>,<a href="http://www.mayoclinicproceedings.com/content/82/4/457.full#ref-34" id=xref-ref-34-9>34</a>,<a href="http://www.mayoclinicproceedings.com/content/82/4/457.full#ref-64" id=xref-ref-64-6>64</a>,<a href="http://www.mayoclinicproceedings.com/content/82/4/457.full#ref-86" id=xref-ref-86-2>86</a></span></sup><span lang=EN style='font-size:9.5pt;font-family:"Lucida Sans Unicode","sans-serif";color:#403838'> (<a href="http://www.mayoclinicproceedings.com/content/82/4/457.full#T4" id=xref-table-wrap-4-1>Table 4</a>). Depending on the mechanism of action of the agent used, it can take from 3 to 10 months before one sees a decrease in sexual desire.</span><sup><span lang=EN style='font-size:8.0pt;font-family:"Lucida Sans Unicode","sans-serif";color:#403838'><a href="http://www.mayoclinicproceedings.com/content/82/4/457.full#ref-64" id=xref-ref-64-7>64</a></span></sup><span lang=EN style='font-size:9.5pt;font-family:"Lucida Sans Unicode","sans-serif";color:#403838'> Medroxyprogesterone acetate, leuprolide acetate, and gonadotropin-releasing hormone agonists have been shown to decrease both deviant and nondeviant sexual drives and behaviors in paraphilic individuals.</span><sup><span lang=EN style='font-size:8.0pt;font-family:"Lucida Sans Unicode","sans-serif";color:#403838'><a href="http://www.mayoclinicproceedings.com/content/82/4/457.full#ref-5" id=xref-ref-5-20>5</a>,<a href="http://www.mayoclinicproceedings.com/content/82/4/457.full#ref-14" id=xref-ref-14-6>14</a>,<a href="http://www.mayoclinicproceedings.com/content/82/4/457.full#ref-34" id=xref-ref-34-10>34</a>,<a href="http://www.mayoclinicproceedings.com/content/82/4/457.full#ref-64" id=xref-ref-64-8>64</a>,<a href="http://www.mayoclinicproceedings.com/content/82/4/457.full#ref-86" id=xref-ref-86-3>86</a></span></sup><span lang=EN style='font-size:9.5pt;font-family:"Lucida Sans Unicode","sans-serif";color:#403838'> Gonadotropin-releasing hormone agonists are becoming the standard of treatment because they have fewer adverse effects and improved efficacy over the older treatments such as medroxyprogesterone acetate.</span><sup><span lang=EN style='font-size:8.0pt;font-family:"Lucida Sans Unicode","sans-serif";color:#403838'><a href="http://www.mayoclinicproceedings.com/content/82/4/457.full#ref-7" id=xref-ref-7-16>7</a>,<a href="http://www.mayoclinicproceedings.com/content/82/4/457.full#ref-34" id=xref-ref-34-11>34</a>,<a href="http://www.mayoclinicproceedings.com/content/82/4/457.full#ref-43" id=xref-ref-43-4>43</a>,<a href="http://www.mayoclinicproceedings.com/content/82/4/457.full#ref-64" id=xref-ref-64-9>64</a></span></sup><span lang=EN style='font-size:9.5pt;font-family:"Lucida Sans Unicode","sans-serif";color:#403838'> Reduced libido also seems to make some offenders more responsive to psychotherapy.</span><sup><span lang=EN style='font-size:8.0pt;font-family:"Lucida Sans Unicode","sans-serif";color:#403838'><a href="http://www.mayoclinicproceedings.com/content/82/4/457.full#ref-5" id=xref-ref-5-21>5</a></span></sup><span lang=EN style='font-size:9.5pt;font-family:"Lucida Sans Unicode","sans-serif";color:#403838'> A drawback to hormone therapy vs castration is its annual cost, which can range from $5000 to $20,000 a year.</span><sup><span lang=EN style='font-size:8.0pt;font-family:"Lucida Sans Unicode","sans-serif";color:#403838'><a href="http://www.mayoclinicproceedings.com/content/82/4/457.full#ref-34" id=xref-ref-34-12>34</a>,<a href="http://www.mayoclinicproceedings.com/content/82/4/457.full#ref-87" id=xref-ref-87-1>87</a></span></sup><span lang=EN style='font-size:9.5pt;font-family:"Lucida Sans Unicode","sans-serif";color:#403838'><o:p></o:p></span></p><p class=MsoPlainText><o:p> </o:p></p><p class=MsoNormal><o:p> </o:p></p><p class=MsoNormal><span style='font-size:12.0pt;color:#1F497D'>Saundra Lund<o:p></o:p></span></p><p class=MsoNormal><span style='font-size:12.0pt;color:#1F497D'>Moscow, ID<o:p></o:p></span></p><p class=MsoNormal><span style='font-size:12.0pt;color:#1F497D'><o:p> </o:p></span></p><p class=MsoNormal><span style='font-size:12.0pt;color:#1F497D'>The only thing necessary for the triumph of evil is for good people to do nothing.<o:p></o:p></span></p><p class=MsoNormal><span style='font-size:12.0pt;color:#1F497D'>~ Edmund Burke<o:p></o:p></span></p><p class=MsoPlainText><o:p> </o:p></p><p class=MsoPlainText>-----Original Message-----<br>From: vision2020-bounces@moscow.com [mailto:vision2020-bounces@moscow.com] On Behalf Of Tom Hansen<br>Sent: Friday, May 06, 2011 9:01 AM<br>To: Ron Force<br>Cc: vision2020@moscow.com<br>Subject: Re: [Vision2020] Angry Hens</p><p class=MsoPlainText><o:p> </o:p></p><p class=MsoPlainText>Just out of curiosity . . .<o:p></o:p></p><p class=MsoPlainText><o:p> </o:p></p><p class=MsoPlainText>Does anybody know if court-ordered castration curtail the possibility of a pedophile re-offending (especially in the case of a serial pedphile)?<o:p></o:p></p><p class=MsoPlainText><o:p> </o:p></p><p class=MsoPlainText>Just a question.<o:p></o:p></p><p class=MsoPlainText><o:p> </o:p></p><p class=MsoPlainText>Tom Hansen<o:p></o:p></p><p class=MsoPlainText>Moscow, Idaho<o:p></o:p></p></div></body></html>